Atlas Trials

Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma

Clinical trial NCT00088881 · TERMINATED

Trial details

NCT number
NCT00088881
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Contiguous Stage II Adult Diffuse Large Cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaSplenic Marginal Zone LymphomaStage I Adult Diffuse Large Cell LymphomaTesticular LymphomaWaldenström Macroglobulinemia
Start date
2004-12-01
Primary completion
2011-03-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.